Press Release

GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation

2023-09-18

GenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNA

2023-08-09

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

2023-08-08

GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit

2023-07-20

GenScript's Subsidiary Bestzyme Secured RMB 250 Million Financing for Synthetic Biology Business

2023-06-01

GenScript Debuts Chip-Based GenTitan™ Gene Fragments Service to Expedite Gene Synthesis at Lower Cost

2023-05-22

GenScript Expands Peptide and Oligonucleotide Production Facility

2023-05-18

ProBio Supports Commercial Manufacturing of the World's First DNA Immunotherapy Targeting HSIL

2023-05-10

GenScript Entered into a Strategic Collaboration Agreement with PersonGen on Cell Isolation Products

2023-03-28

GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service

2023-02-28

Cell and Gene Therapy Companies Leverage GenScript’s cGMP sgRNA Capability to Accelerate Speed to Market

2022-12-15

GenScript supported approval of its partner's nasal spray for COVID-19 protection in Thailand

2022-10-17

GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreaking Non-Viral Cell Therapy Study

2022-09-22

GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process

2022-09-20

GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development

2022-05-16

GenScript Biotech Expands to the United Kingdom with New Offices and Logistics Center | GenScript

2021-12-16

GenScript Launches Closed-End Double Stranded DNA Service for CRISPR | GenScript

2021-11-30

GenScript Biotech Reports First Half 2021 Results | GenScript

2021-08-24

GenScript receives "Best Contract Development and Manufacturing Organization Award" in the Korea Bioprocessing Excellence Awards 2021

2021-06-29

Duke NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test | GenScript

2021-06-21